Condition: Heart Failure · Univentricular Heart · Ventricular Dysfunction · Sponsor: Berlin Heart GmbH
The purpose of the study is to monitor the clinical safety and performance of the EXCOR Venous Cannula in context of an EXCOR VAD therapy to ensure continued acceptability of identified risks, to enable detecting emerging risks and to assess clinical improvement on both short- and long-term.
This description comes directly from the study's public registry record.
Thomas Schöndorf, Dr. Dr. PD · +49 30 81872600 · clinical.science@berlinheart.de
Eleonora Dal Sasso, Dr. · +49 30 81872600 · clinical.science@berlinheart.de
Always discuss trial participation with your own doctor first.
| LMU Klinikum | Munich, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04782232